-
Stakeholder Engagement in the Economic Evaluation of Site-Specific Wastewater-Based Surveillance for Preventing COVID-19 Outbreaks in Long-Term Care Facilities
Sep 9, 2025, 16:22 PM -
Clinical Management and Outcomes of Patients in England With eGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Observational Study and Its Impact on UK Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Economic Burden Utilities and Cost-Effectiveness of Perioperative Immunotherapies for Early Stage Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Improving Pulmonary Tuberculosis Treatment Outcomes Through Pharmacist-Led Education: Findings From a Malaysian Randomized Control Trial
Sep 9, 2025, 16:22 PM -
Establishing Robust and Adaptive Willingness-to-Pay Thresholds for Taiwan's National Health Insurance: A Case Study of Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
Five-Year Inpatient Hospital Trends of COVID-19 Admissions in US Medicare Fee for Service
Sep 9, 2025, 16:22 PM -
Linking Data to Care: Mining the Pathways of Oncology
Sep 9, 2025, 16:22 PM -
Development of an AI-Powered Tool to Accelerate and Enhance Systematic Literature Reviews for Evidence-Based Decision Making in Clinical Research
Sep 9, 2025, 16:22 PM -
DII Mentoring Project— Patient Associations as a Catalyst for Quality-Of-Life Improvement and Positive Economic Impact in Inflammatory Bowel Disease
Sep 9, 2025, 16:22 PM -
Navigating HTA and Innovation: Oncologists’ Perspectives on Access to Cancer Therapies in Bulgaria
Sep 9, 2025, 16:22 PM -
Changes in the Epidemiological Indicators of Female Infertility in Europe 1991-2021
Sep 9, 2025, 16:22 PM -
Unlocking Value Early: Insights Into NICE’s Early Value Assessments and Evidence-Generation Plans for Medical Technologies
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Inclisiran for the Management of Patients With Atherosclerotic Cardiovascular Disease in India: A Multipayer Analysis
Sep 9, 2025, 16:22 PM -
Is There Sufficient Economic Evidence for Reimbursing Behavioral Interventions? A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Genomic Testing for Early Breast Cancer: Assessing the Value of Next-Generation Sequencing
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Costs Among Bacillus Calmette-Guérin (BCG)-Experienced or Unresponsive Patients With Papillary-Only High-Risk Non–Muscle Invasive Bladder Cancer
Sep 9, 2025, 16:22 PM -
Bimekizumab Cost per Responder Analysis Compared to Other Licensed Interleukin Inhibitors at Week 52 for the Treatment of Psoriatic Arthritis: A United Kingdom Perspective
Sep 9, 2025, 16:22 PM -
A Two-Stage Bayesian Approach for Real-World Cost-Effectiveness Analysis: Combining Inverse Probability Weighting With Gamma-Beta Regression Model
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of GLP-1 Receptor Agonists for Type 2 Diabetes Management in India
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of rhTNK-tPA vs. rt-PA for Acute Ischemic Stroke Patients Within 4.5H of Symptom Onset in China
Sep 9, 2025, 16:22 PM
